Sign Up to like & get
recommendations!
2
Published in 2022 at "Clinical Rheumatology"
DOI: 10.1007/s10067-022-06124-z
Abstract: We report the case of an 18-year-old male with Still’s disease for the last 3 years, in remission, who developed two flares of his disease after receiving two doses of the ChAdOX1 nCoV-19 vaccine. While…
read more here.
Keywords:
two doses;
flares still;
doses chadox1;
vaccine ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "International Journal of Epidemiology"
DOI: 10.1093/ije/dyac199
Abstract: Abstract Background Several SARS-CoV-2 vaccines have been shown to provide protection against COVID-19 hospitalization and death. However, some evidence suggests that notable waning in effectiveness against these outcomes occurs within months of vaccination. We undertook…
read more here.
Keywords:
first second;
bnt162b2;
covid;
target trial ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Annals of Laboratory Medicine"
DOI: 10.3343/alm.2022.42.6.688
Abstract: Following the original severe acute respiratory syndrome coronavirus 2 strain (Wuhan-Hu-1) in December 2019, the Delta variant in May 2021 and the Omicron variant in December 2021 were classified as variants of concern. The pandemic…
read more here.
Keywords:
immunogenicity third;
doses chadox1;
bnt162b2;
third dose ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Immune Network"
DOI: 10.4110/in.2022.22.e24
Abstract: Coronavirus disease 2019 (COVID-19) vaccination in immunocompromised, especially transplant recipients, may induce a weaker immune response. But there are limited data on the immune response after COVID-19 vaccination in liver transplant (LT) recipients, especially on…
read more here.
Keywords:
response;
mrna 1273;
two doses;
vaccine ... See more keywords